MassMutual Private Wealth & Trust’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5K Sell
37
-9
-20% -$546 ﹤0.01% 1936
2026
Q1
$2.55K Buy
46
+34
+283% +$1.83K ﹤0.01% 1909
2025
Q4
$582 Hold
12
﹤0.01% 2225
2025
Q3
$367 Hold
12
﹤0.01% 2283
2025
Q2
$266 Hold
12
﹤0.01% 2287
2025
Q1
$223 Sell
12
-102
-89% -$1.7K ﹤0.01% 2294
2024
Q4
$1.51K Buy
114
+102
+850% +$2.47K ﹤0.01% 1916
2024
Q3
$402 Hold
12
﹤0.01% 2007
2024
Q2
$301 Hold
12
﹤0.01% 2022
2024
Q1
$270 Hold
12
﹤0.01% 1953
2023
Q4
$257 Buy
+12
New +$207 ﹤0.01% 1898

Other funds holding ANAB

MassMutual Private Wealth & Trust's ANAB Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its AnaptysBio (ANAB) stake by 20% in Q2 2026, selling an estimated $546 and leaving 37 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

MassMutual Private Wealth & Trust first reported a position in ANAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.55K in Q1 2026. 35 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • MassMutual Private Wealth & Trust held 37 shares of AnaptysBio worth $2.5K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 9 AnaptysBio shares in Q2 2026, an estimated $546.
  • AnaptysBio made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1936 holding.
  • MassMutual Private Wealth & Trust first reported a position in AnaptysBio in Q4 2023 and has held it in 11 quarters since.
  • MassMutual Private Wealth & Trust's AnaptysBio position peaked at $2.55K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.